Literature DB >> 27132186

Identification of striated muscle activator of Rho signaling (STARS) as a novel calmodulin target by a newly developed genome-wide screen.

Yusui Furuya1, Miwako Denda2, Kyohei Sakane1, Tomoko Ogusu1, Sumio Takahashi3, Masaki Magari1, Naoki Kanayama1, Ryo Morishita2, Hiroshi Tokumitsu4.   

Abstract

To search for novel target(s) of the Ca(2+)-signaling transducer, calmodulin (CaM), we performed a newly developed genome-wide CaM interaction screening of 19,676 GST-fused proteins expressed in human. We identified striated muscle activator of Rho signaling (STARS) as a novel CaM target and characterized its CaM binding ability and found that the Ca(2+)/CaM complex interacted stoichiometrically with the N-terminal region (Ala13-Gln35) of STARS in vitro as well as in living cells. Mutagenesis studies identified Ile20 and Trp33 as the essential hydrophobic residues in CaM anchoring. Furthermore, the CaM binding deficient mutant (Ile20Ala, Trp33Ala) of STARS further enhanced its stimulatory effect on SRF-dependent transcriptional activation. These results suggest a connection between Ca(2+)-signaling via excitation-contraction coupling and the regulation of STARS-mediated gene expression in muscles.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ca(2+) signaling; Calmodulin; Genome-wide screening; Protein-protein interaction; STARS

Mesh:

Substances:

Year:  2016        PMID: 27132186     DOI: 10.1016/j.ceca.2016.04.004

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  1 in total

1.  Isogenic human pluripotent stem cell disease models reveal ABRA deficiency underlies cTnT mutation-induced familial dilated cardiomyopathy.

Authors:  Bin Li; Yongkun Zhan; Qianqian Liang; Chen Xu; Xinyan Zhou; Huanhuan Cai; Yufan Zheng; Yifan Guo; Lei Wang; Wenqing Qiu; Baiping Cui; Chao Lu; Ruizhe Qian; Ping Zhou; Haiyan Chen; Yun Liu; Sifeng Chen; Xiaobo Li; Ning Sun
Journal:  Protein Cell       Date:  2021-04-22       Impact factor: 14.870

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.